Incidence and risk factors of hypotension-related adverse events among Japanese patients with heart failure receiving sacubitril/valsartan or enalapril: Results from the PARALLEL-HF study
Incidence of hypotension-related AEs was higher in the sacubitril/valsartan versus enalapril group but did not affect risk of cardiovascular death or HF hospitalization, which was similar between treatment groups.
Authors
- Hiroshi Ito (ORCID: https://orcid.org/0000-0002-9857-8614)
- Yasushi Sakata (ORCID: https://orcid.org/0000-0002-5618-4721)
- Toshihito Kitamura
- Takayuki Iimori
- Yoshihiko Saito (ORCID: https://orcid.org/0000-0001-5574-3571)
- Hiroyuki Tsutsui (ORCID: https://orcid.org/0000-0002-5291-2875)
- Kazuhiro Yamamoto (ORCID: https://orcid.org/0000-0001-5647-6735)
- Tomomi Ohishi
- Shin-ichi Momomura
Institutions
- National Archives and Records Administration (US)
- Kawasaki Medical School (JP)
- Hiroshima City Asa Citizens Hospital (JP)
- Novartis (Japan) (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of Cardiology
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1016/j.jjcc.2024.09.002
- Citations
- 5
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Novartis Pharmaceuticals Corporation